Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Klungel, O. H.
Right arrow Articles by Psaty, B. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klungel, O. H.
Right arrow Articles by Psaty, B. M.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*High Blood Pressure
*Stroke
Related Collections
Right arrow Cerebrovascular disease/stroke
Right arrow Acute Cerebral Hemorrhage
Right arrow Acute Cerebral Infarction
Right arrow Risk Factors for Stroke

(Stroke. 2000;31:420.)
© 2000 American Heart Association, Inc.


Original Contributions

Control of Blood Pressure and Risk of Stroke Among Pharmacologically Treated Hypertensive Patients

Olaf H. Klungel, PharmD, PhD; Robert C. Kaplan, MS, PhD; Susan R. Heckbert, MD, PhD; Nicholas L. Smith, MPH, PhD; Rozenn N. Lemaitre, MPH, PhD; W. T. Longstreth, Jr, MD, MPH; Hubert G. M. Leufkens, PharmD, PhD; Anthonius de Boer, MD, PhD Bruce M. Psaty, MD, PhD

From the Departments of Epidemiology (O.H.K., R.C.K., B.M.P., S.R.H., W.T.L.), Medicine (B.M.P., N.L.S., R.N.L., W.T.L.), Health Services (B.M.P.), and Neurology (W.T.L.), Cardiovascular Health Research Unit, University of Washington, Seattle; and the Department of Pharmacoepidemiology and Pharmacotherapy (O.H.K., H.G.M.L., A. de B.), Utrecht Institute of Pharmaceutical Sciences, Utrecht University (Netherlands).

Correspondence to Olaf H. Klungel, Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute of Pharmaceutical Sciences, Utrecht University, PO Box 80082, 3508 TB, Utrecht, Netherlands. E-mail o.h.klungel{at}pharm.uu.nl

Background and Purpose—Despite improved control of blood pressure during the last decades in the United States, a considerable proportion of treated hypertensives have not achieved target blood pressure levels. We estimated the proportion of strokes occurring among treated hypertensive patients that may be attributable to uncontrolled blood pressure.

Methods—A population-based case-control study was conducted among treated hypertensive members of Group Health Cooperative of Puget Sound. Cases were treated hypertensive patients who sustained a first fatal or nonfatal, ischemic (n=460) or hemorrhagic (n=95) stroke during 1989–1996. Controls were a random sample of stroke-free, treated hypertensive Group Health Cooperative enrollees (n=2966), similar in age to the stroke cases. Multiple measurements of blood pressure and other cardiovascular risk factors were collected from medical records. Logistic regression was used to estimate the risk of ischemic stroke and hemorrhagic stroke associated with uncontrolled blood pressure, defined as diastolic blood pressure >90 mm Hg or systolic blood pressure >140 mm Hg. The fraction of strokes attributable to uncontrolled blood pressure among treated hypertensives was calculated.

Results—Blood pressure was uncontrolled in 78% of ischemic stroke cases, 85% of hemorrhagic stroke cases, and 65% of controls. After adjustment for potential confounders, uncontrolled blood pressure among treated hypertensive patients was moderately associated with ischemic stroke (risk ratio=1.5 [95% CI, 1.2 to 1.9]) and strongly related to hemorrhagic stroke (risk ratio=3.0 [95% CI, 1.7 to 5.4]). We estimated that 27% (95% CI, 11% to 39%) of the ischemic strokes and 57% (95% CI, 26% to 75%) of the hemorrhagic strokes among treated hypertensive patients were attributable to uncontrolled blood pressure. Overall, 32% (95% CI, 14% to 45%) of all strokes were attributable to uncontrolled blood pressure.

Conclusions—A considerable proportion of incident strokes among treated hypertensive patients may be prevented by achieving control of blood pressure.


Key Words: hypertension • pharmacology • risk • stroke, hemorrhagic • stroke, ischemic




This article has been cited by other articles:


Home page
StrokeHome page
D. Samal, S. Greisenegger, E. Auff, W. Lang, and W. Lalouschek
The Relation Between Knowledge About Hypertension and Education in Hospitalized Patients With Stroke in Vienna
Stroke, April 1, 2007; 38(4): 1304 - 1308.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Rienstra, D. J. Van Veldhuisen, H. J.G.M. Crijns, I. C. Van Gelder, and for the RACE investigators
Enhanced cardiovascular morbidity and mortality during rhythm control treatment in persistent atrial fibrillation in hypertensives: data of the RACE study
Eur. Heart J., March 2, 2007; 28(6): 741 - 751.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. Li, G. Engstrom, B. Hedblad, G. Berglund, and L. Janzon
Blood Pressure Control and Risk of Stroke: A Population-Based Prospective Cohort Study
Stroke, April 1, 2005; 36(4): 725 - 730.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
P. Sookaneknun, R. M. Richards, J. Sanguansermsri, and C. Teerasut
Pharmacist Involvement in Primary Care Improves Hypertensive Patient Clinical Outcomes
Ann. Pharmacother., December 1, 2004; 38(12): 2023 - 2028.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
B. M. Psaty, T. A. Manolio, N. L. Smith, S. R. Heckbert, J. S. Gottdiener, G. L. Burke, J. Weissfeld, P. Enright, T. Lumley, N. Powe, et al.
Time Trends in High Blood Pressure Control and the Use of Antihypertensive Medications in Older Adults: The Cardiovascular Health Study
Arch Intern Med, November 11, 2002; 162(20): 2325 - 2332.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
G. Friday, M. Alter, and S.-M. Lai
Control of Hypertension and Risk of Stroke Recurrence
Stroke, November 1, 2002; 33(11): 2652 - 2657.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
M. Kivipelto, E.-L. Helkala, M. P. Laakso, T. Hanninen, M. Hallikainen, K. Alhainen, S. Iivonen, A. Mannermaa, J. Tuomilehto, A. Nissinen, et al.
Apolipoprotein E {epsilon}4 Allele, Elevated Midlife Total Cholesterol Level, and High Midlife Systolic Blood Pressure Are Independent Risk Factors for Late-Life Alzheimer Disease
Ann Intern Med, August 6, 2002; 137(3): 149 - 155.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
M. Kivipelto, E.-L. Helkala, M. P Laakso, T. Hanninen, M. Hallikainen, K. Alhainen, H. Soininen, J. Tuomilehto, and A. Nissinen
Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study
BMJ, June 16, 2001; 322(7300): 1447 - 1451.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. L. Eigenbrodt, K. M. Rose, D. J. Couper, D. K. Arnett, R. Smith, and D. Jones
Orthostatic Hypotension as a Risk Factor for Stroke : The Atherosclerosis Risk in Communities (ARIC) Study, 1987-1996
Stroke, October 1, 2000; 31(10): 2307 - 2313.
[Abstract] [Full Text] [PDF]